199 related articles for article (PubMed ID: 34627251)
61. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
62. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
63. Prognostic Value of Peripheral Blood Lymphocyte/monocyte Ratio in Lymphoma.
Gao F; Hu J; Zhang J; Xu Y
J Cancer; 2021; 12(12):3407-3417. PubMed ID: 33995619
[No Abstract] [Full Text] [Related]
64. RCHOP-14 therapy versus RCHOP-21 therapy for people with aggressive or advanced-stage indolent B-cell non-Hodgkins lymphoma: a systematic review and meta-analysis.
He Y; Tao W; Ji D; Lu W; Xiong Y; Chen G
Transl Cancer Res; 2021 May; 10(5):2044-2054. PubMed ID: 35116526
[TBL] [Abstract][Full Text] [Related]
65. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
[TBL] [Abstract][Full Text] [Related]
66. Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.
La Mura V; De Renzo A; Perna F; D'Agostino D; Masarone M; Romano M; Bruno S; Torella R; Persico M
J Hepatol; 2008 Oct; 49(4):557-63. PubMed ID: 18678434
[TBL] [Abstract][Full Text] [Related]
67. [Analysis for clinicopathological features, therapy and prognosis of 30 elderly patients with non-Hodgkin's lymphoma].
Wang HT; Yang B; Cai LL; Ran HH; Zhang WY; Zhu HL; Yang Y; Li SX; Fan H; Chi XH; Yu RL; Zhang F; Li BL; Lin J; Zhai B; Yao SQ; Lu XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1464-70. PubMed ID: 24370030
[TBL] [Abstract][Full Text] [Related]
68. Diabetes and the Prognosis in Patients With Non-Hodgkin Lymphoma: A Meta-analysis of Cohort Studies.
Han Z; Xu H; Zhao M; Jing F; Xue H; Xiao S
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):e77-e88. PubMed ID: 34593361
[TBL] [Abstract][Full Text] [Related]
69. Survival after subsequent non-Hodgkin's lymphoma and non-small cell lung cancer in patients with malignant thymoma.
Parzen JS; Bates JE; Milano MT; Dhakal S
J Thorac Dis; 2016 Dec; 8(12):3605-3613. PubMed ID: 28149555
[TBL] [Abstract][Full Text] [Related]
70. Hepatitis C Virus Infection and Treatment as Independent Prognostic Factors in Diffuse Large B-Cell Lymphoma Egyptian Patients.
Elbedewy TA; Elashtokhy HEA; Abd-Elsalam S; Suliman MA
Curr Cancer Drug Targets; 2020; 20(8):638-645. PubMed ID: 32392114
[TBL] [Abstract][Full Text] [Related]
71. Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: a meta-analysis.
Dong HJ; Ni LN; Sheng GF; Song HL; Xu JZ; Ling Y
J Clin Virol; 2013 Jul; 57(3):209-14. PubMed ID: 23562041
[TBL] [Abstract][Full Text] [Related]
72. Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options.
Pozzato G; Mazzaro C; Dal Maso L; Mauro E; Zorat F; Moratelli G; Bulian P; Serraino D; Gattei V
World J Hepatol; 2016 Jan; 8(2):107-16. PubMed ID: 26807206
[TBL] [Abstract][Full Text] [Related]
73. Association between hepatitis B virus/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population.
Li L; Lan X
J Cancer Res Ther; 2016 Dec; 12(Supplement):C284-C287. PubMed ID: 28230038
[TBL] [Abstract][Full Text] [Related]
74. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
Skoetz N; Will A; Monsef I; Brillant C; Engert A; von Tresckow B
Cochrane Database Syst Rev; 2017 May; 5(5):CD007941. PubMed ID: 28541603
[TBL] [Abstract][Full Text] [Related]
75. Hepatitis B&C virus infection in cases of Non-Hodgkin's lymphoma in Saudi Arabia.
Mehdi SR; Al Ajlan AR
Turk J Haematol; 2006 Dec; 23(4):200-4. PubMed ID: 27265663
[TBL] [Abstract][Full Text] [Related]
76. Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.
Arcaini L; Vallisa D; Rattotti S; Ferretti VV; Ferreri AJM; Bernuzzi P; Merli M; Varettoni M; Chiappella A; Ambrosetti A; Tucci A; Rusconi C; Visco C; Spina M; Cabras G; Luminari S; Tucci M; Musto P; Ladetto M; Merli F; Stelitano C; d'Arco A; Rigacci L; Levis A; Rossi D; Spedini P; Mancuso S; Marino D; Bruno R; Baldini L; Pulsoni A
Ann Oncol; 2014 Jul; 25(7):1404-1410. PubMed ID: 24799461
[TBL] [Abstract][Full Text] [Related]
77. Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization.
Torres HA; Mahale P
Liver Int; 2015 Jun; 35(6):1661-4. PubMed ID: 25779000
[TBL] [Abstract][Full Text] [Related]
78. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Majolino I; Pearce R; Taghipour G; Goldstone AH
J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
[TBL] [Abstract][Full Text] [Related]
79. Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin's lymphoma (B-NHL) chemotherapy: a meta-analysis.
Hua Q; Zhu Y; Liu H
J Chemother; 2015; 27(6):365-70. PubMed ID: 25872413
[TBL] [Abstract][Full Text] [Related]
80. The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysis.
Yıldırım M; Kaya V; Demirpençe Ö; Paydaş S
Arch Med Sci; 2015 Aug; 11(4):708-14. PubMed ID: 26322081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
